Treatment of Dry Cough Bronchitis in Adults
For immunocompetent adults with dry cough due to acute bronchitis, do not routinely prescribe any medications—including antibiotics, antitussives, inhaled bronchodilators, corticosteroids, or NSAIDs—as these have not been shown to safely and effectively reduce cough severity or duration. 1
Primary Management Approach
Watchful Waiting and Reassurance
- Provide symptomatic support only (hydration, rest) and educate patients that acute bronchitis is self-limited, with cough typically lasting 2-3 weeks 2
- No routine investigations are recommended at initial presentation—avoid chest x-ray, spirometry, sputum cultures, viral PCR, or inflammatory markers unless alternative diagnoses are suspected 1
- Antibiotics provide no meaningful benefit: while they may shorten cough duration by approximately 0.5 days, this minimal effect is outweighed by antibiotic-related adverse effects and does not justify routine use 2
What NOT to Prescribe
The 2020 CHEST Expert Panel guideline explicitly recommends against routine prescription of: 1
- Antibiotic therapy
- Antiviral therapy
- Antitussives (cough suppressants)
- Inhaled beta-agonists
- Inhaled anticholinergics
- Inhaled corticosteroids
- Oral corticosteroids 3
- Oral NSAIDs (ibuprofen showed no difference versus placebo in reducing cough duration) 1
The evidence base for commonly used antitussive combinations (codeine, dextromethorphan, antihistamines) in nonspecific cough remains weak despite widespread use 4
When to Reassess and Escalate
Indications for Re-evaluation
If cough persists beyond 3 weeks or worsens, reassess the patient and consider: 1
- Targeted investigations: chest x-ray, sputum culture, peak flow measurements, complete blood count, C-reactive protein 1
- Alternative diagnoses that may have been missed initially
Critical Differential Diagnoses to Exclude
Before confirming acute bronchitis, rule out conditions that do require specific treatment: 1
Asthma or cough-variant asthma:
- In one retrospective study, 65% of patients with recurrent "acute bronchitis" episodes actually had mild asthma 1
- These patients may benefit from inhaled corticosteroids and bronchodilators
COPD exacerbation:
- Patients with underlying COPD experiencing acute worsening may require oral corticosteroids 3
- Look for baseline chronic symptoms, smoking history, and spirometric evidence of obstruction
Pneumonia:
- Check vital signs: heart rate >100 bpm, respiratory rate >24 breaths/min, or temperature >38°C suggest pneumonia rather than simple bronchitis 5
- These patients require chest imaging and may need antibiotics
Pertussis:
- Consider in patients with cough lasting >2-3 weeks, especially with paroxysmal cough or post-tussive vomiting 6
- Antibiotics (macrolides) are indicated to reduce transmission 6
Bronchiectasis exacerbation:
- Patients with known or suspected bronchiectasis require different management strategies 1
When Antibiotics May Be Considered
Only prescribe antibiotics if:
- Clinical worsening occurs and a complicating bacterial infection becomes likely (e.g., development of pneumonia) 1
- Pertussis is suspected to reduce transmission 6
- The patient is ≥65 years old and at increased risk of developing pneumonia 6
Common Pitfalls to Avoid
Patient expectation management:
- Many patients expect antibiotics or cough suppressants; effective communication is essential 6
- Describe acute bronchitis as a "chest cold" and explain the expected 2-3 week duration 2
- Studies show that patient education and delayed antibiotic prescriptions can reduce antibiotic use without increasing return visits or patient dissatisfaction 5
Misdiagnosis of underlying asthma:
- A substantial proportion of patients labeled with "recurrent acute bronchitis" actually have undiagnosed asthma 1
- Consider trial of bronchodilators if there is clinical suspicion of bronchial hyperreactivity, but this is not routine for first-time acute bronchitis 5
Inappropriate corticosteroid use: